ResMed has introduced new products designed to enhance sleep apnea therapy through personalized, AI-driven tools. These solutions integrate with popular wearable devices, offering users insights into their sleep health and empowering them to take an active role in their therapy. The 2024 ResMed Global Sleep Survey revealed that 44% of Americans experience poor sleep, highlighting the need for such innovations.
The enhanced ResMed myAir app now features smartwatch integration, sleep stage tracking, and personalized coaching, helping patients stay engaged with their CPAP therapy. By providing holistic health data alongside therapy insights, the app aids users in understanding their overall well-being. ResMed also launched Dawn, a generative AI-powered sleep health concierge that offers real-time, personalized support and information on sleep therapy.
Additionally, ResMed introduced its LUXE line of travel gear, designed specifically for CPAP users who need sophisticated and practical solutions on the go. The new products are available for purchase online starting October 28, 2024, and reflect ResMed’s ongoing commitment to improving patient health and therapy adherence.
Click here to read the original news story.